Financials

News Ideas Discussions Technicals Forecast Seasonals

Non-operating income, total of TransCode Therapeutics, Inc.

Annual data

2020

2021

2022

2023

TTM

‪‪−1.80 M‬‬

‪‪−900.00 K‬‬

‪0.00‬

‪‪900.00 K‬‬

‪‪1.80 M‬‬

Period

Value

Change

Change %

TTM

‪‪−299.22 K‬‬

‪‪−1.17 M‬‬

‪−134.30‬%

2023

‪‪872.42 K‬‬

‪‪−228.43 K‬‬

‪−20.75‬%

2022

‪‪1.10 M‬‬

+‪‪1.79 M‬‬

—

2021

‪‪−692.26 K‬‬

+‪‪925.03 K‬‬

+‪57.20‬%

2020

‪‪−1.62 M‬‬

‪‪−1.47 M‬‬

‪−975.70‬%

Quarterly data

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−300.00 K‬‬

‪0.00‬

‪‪300.00 K‬‬

‪‪600.00 K‬‬

‪‪900.00 K‬‬

Period

Value

Change

Change %

Q3 '24

‪‪−155.98 K‬‬

‪‪−79.09 K‬‬

‪−102.85‬%

Q2 '24

‪‪−76.89 K‬‬

‪‪−39.06 K‬‬

‪−103.26‬%

Q1 '24

‪‪−37.83 K‬‬

‪‪−9.32 K‬‬

‪−32.68‬%

Q4 '23

‪‪−28.51 K‬‬

‪‪−56.09 K‬‬

‪−203.41‬%

Q3 '23

‪‪27.57 K‬‬

‪‪−761.61 K‬‬

‪−96.51‬%

Q2 '23

‪‪789.18 K‬‬

+‪‪705.00 K‬‬

+‪837.51‬%

Q1 '23

‪‪84.18 K‬‬

‪‪−309.22 K‬‬

‪−78.60‬%

Q4 '22

‪‪393.40 K‬‬

‪‪−270.55 K‬‬

‪−40.75‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20